卡博替尼能提高不同肿瘤组织学和既往接受过抗血管内皮生长因子疗法的放射性碘难治性分化型甲状腺癌患者的无进展生存期

{"title":"卡博替尼能提高不同肿瘤组织学和既往接受过抗血管内皮生长因子疗法的放射性碘难治性分化型甲状腺癌患者的无进展生存期","authors":"Simone de Leo","doi":"10.1089/ct.2024;36.71-73","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":504944,"journal":{"name":"Clinical Thyroidology®","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cabozantinib Increases Progression–free Survival in Radioiodine–Refractory Differentiated Thyroid Cancer across Tumor Histologies and after Previous Anti–VEGF Therapy\",\"authors\":\"Simone de Leo\",\"doi\":\"10.1089/ct.2024;36.71-73\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":504944,\"journal\":{\"name\":\"Clinical Thyroidology®\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Thyroidology®\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ct.2024;36.71-73\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Thyroidology®","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ct.2024;36.71-73","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}